King Pharmaceuticals Announces Cross-license Agreement With Mutual Pharmaceutical Company
December 09, 2005
Document related to this release.
# # #
Contacts:
Jack Howarth, Vice President, Investor Relations
908-429-8350
Executive Offices:
King Pharmaceuticals
501 Fifth Street
Bristol, Tennessee 37620
